About 10,033 results

ALLMedicine™ Cardiogenic Shock Center

Research & Reviews  3,373 results

"Enrolling patients in Cardiogenic shock Trials: are we missing someone? Insights from ...
European Journal of Heart Failure; Pappalardo F, Tavazzi G et. al.

Aug 7th, 2022 - "Enrolling patients in Cardiogenic shock Trials: are we missing someone? Insights from Italian Alt Shock-2 Registry".|2022|Pappalardo F,Tavazzi G,Savonitto S,Moricci N,|

Impact of the elevated angiopoietin-2 levels during Impella support on the short-term p...
Journal of Artificial Organs : the Official Journal of Th... Nakamura M, Imamura T et. al.

Aug 7th, 2022 - Elevated serum angiopoietin-2 levels in patients with acute myocardial infarction-related cardiogenic shock with and without intra-aortic balloon pump as well as acute decompensated heart failure are associated with short-term mortality. However, ...

How does protocolization improve outcomes in cardiogenic shock due to end-stage heart f...
International Journal of Cardiology; Lim HS

Aug 6th, 2022 - Protocolized team-based care has been shown to improve outcomes in cardiogenic shock (CS) in patients with end-stage heart failure (ESHF). This study tested the hypothesis that protocolized care improves survival by reducing multi-organ dysfunctio...

A year ReviewED: Top emergency medicine pharmacotherapy articles of 2021.
The American Journal of Emergency Medicine; Brown CS, Sarangarm P et. al.

Aug 6th, 2022 - This article highlights the most relevant emergency medicine (EM) pharmacotherapy publications indexed in 2021. A modified Delphi approach was utilized for selected journals to identify the most impactful EM pharmacotherapy studies via the GRADE s...

Vasoactive pharmacological management according to SCAI class in patients with acute my...
PloS One; Udesen NLJ, Helgestad OKL et. al.

Aug 5th, 2022 - Vasoactive treatment is a cornerstone in treating hypoperfusion in cardiogenic shock following acute myocardial infarction (AMICS). The purpose was to compare the achievement of treatment targets and outcome in relation to vasoactive strategy in A...

see more →

Drugs  55 results see all →

Clinicaltrials.gov  263 results

Pulmonary Artery Catheter in Cardiogenic Shock Trial

Aug 3rd, 2022 - The PACCS trial is a multicenter, randomized, parallel group, adaptive trial that will test the hypothesis that early invasive hemodynamic assessment (within 6 hours of randomization) and ongoing management with a PAC decreases in-hospital mortali...

Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients

Jul 28th, 2022 - The current study hypothesizes that The SCS treatment with the icor kit provides sufficient support for cardiocirculatory function as indicated by a significant lactate reduction 24 hours on SCS treatment versus before treatment start. Patients wi...

Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation

Jul 27th, 2022 - Study Objectives: To determine the effect of early left atrial septostomy versus conventional approach(left atrial septostomy only in cases of significant changes due to left ventricular end-diastolic pressure increase) in patients who received ve...

Cangrelor in Patients With Acute Myocardial Infarction Undergoing PCI After CPR, Ventilated or Cardiogenic Shock

Jul 27th, 2022 - This registry is a non-interventional, multicentre, retrospective cohort study in patients with acute myocardial infarction undergoing PCI after CRP, ventilated and/or with cardiogenic shock. The study is purely observational; data will be documen...

Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock

Jul 26th, 2022 - Scientific background - Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is used more and more frequently in patients with acute myocardial infarction (AMI) and refractory cardiogenic shock despite the absence of high level scientific ev...

see more →

News  318 results

Impella Pump for MI With Cardiogenic Shock Again Fares Poorly vs IABP in Study

Jul 26th, 2022 - Another observational study has questioned whether Impella ventricular assist pumps (Abiomed) should be used in patients with acute myocardial infarction (MI) complicated by cardiogenic shock (CS), at least compared with an intra-aortic balloon pu...

The Significance of the 'Creatinine Bump'

Jul 13th, 2022 - This transcript has been edited for clarity. Matthew F. Watto, MD: Welcome back to The Curbsiders. I'm Dr Matthew Watto, here with my great friend, Dr Paul Nelson Williams. Paul, how are you doing today? Paul N. Williams, MD: I'm great. We're talk...

Takotsubo Syndrome More Deadly in Men

May 26th, 2022 - Takotsubo syndrome occurs much more frequently in women than it does in men, but men are much more likely to die from it, according to the results of a new study. In an analysis of almost 2,500 patients with Takotsubo syndrome (TSS) who were enrol...

Takotsubo syndrome more deadly in men
Fran Lowry

May 25th, 2022 - Takotsubo syndrome occurs much more frequently in women than it does in men, but men are much more likely to die from it, according to the results of a new study. In an analysis of almost 2,500 patients with Takotsubo syndrome (TSS) who were enrol.

ACC Recognizes Alain Cribier, MD, PhD, for Developing TAVR

Apr 21st, 2022 - This article was originally published in French on Medscape. WASHINGTON, DC — By giving Alain Cribier, MD, PhD, professor emeritus at Rouen University Hospital in Rouen, France, the Presidential Citation Award, the American College of Cardiology C...

see more →

Patient Education  4 results see all →